Novel approach to inhibit asthma-mediated lung inflammation using Anti-CD147 intervention

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4870-4879

  Gwinn, William M ^a   Damsker, Jesse M ^a   Falahati, Rustom ^a   Okwumabua, Ifeanyi ^a   Kelly Welch, Ann ^b   Keegan, Achsah D ^b   Vanpouille, Christophe ^a   Lee, James J ^c   Dent, Lindsay A ^d   Leitenberg, David ^a   Bukrinsky, Michael I ^a   Constant, Stephanie L ^a,e  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CYCLOPHILIN; METHACHOLINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD147; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TARGETING; EFFECTOR CELL; EOSINOPHIL; FEMALE; INFLAMMATION; LEUKOCYTE ADHERENCE; LYMPHOCYTE ACTIVATION; MEMORY CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 33749129213     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4870     Document Type: Article

References (58)

1. Cohn, L., J. Elias, and G. Chupp. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22: 789-815.
2. Larche, M., D. S. Robinson, and A. B. Kay. 2003. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111: 450-463.
3. Bisset, L. R., and P. Schmid-Grendelmeier. 2005. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr. Opin. Pulm. Med. 11: 35-42.
4. Lloyd, C. M., and S. M. Rankin. 2003. Chemokines in allergic airway disease. Curr. Opin. Pharmacol. 3: 443-448.
5. Elsner, J., S. E. Escher, and U. Forssmann. 2004. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 59: 1243-1258.
6. Bukrinsky, M. I. 2002. Cyclophilins: unexpected messengers in intercellular communications. Trends Immunol. 23: 323-325.
7. Wang, P., and J. Heitman. 2005. The cyclophilins. Genome Biol. 6: 226.1-226.6.
8. Saphire, A., M. Bobardt, and P. Gallay. 1999. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18: 6771-6785.
9. Handschumacher, R. E., M. Harding, J. Rice, R. Drugge, and D. Speicher. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226: 544-547.
10. Sherry, B., N. Yartlett, A. Strupp, and A. Cerami. 1992. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc. Natl. Acad. Sci. USA 89: 3511-3515.
11. Jin, Z. G., M. G. Melaragno, D. F. Liao, C. Yan, J. Haendeler, Y. A. Suh, J. D. Lambeth, and B. C. Berk. 2000. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ. Res. 87: 789-796.
12. Spik, G., B. Haendler, O. Delmas, C. Mariller, M. Chamoux, P. Maes, A. Tartar, J. Montreuil, K. Stedman, H. P. Kocher, et al. 1991. A novel secreted cyclophilin-like protein (SCYLP). J. Biol. Chem. 266: 10735-10738.
13. Allain, F., C. Boutillon, C. Mariller, and G. Spik. 1995. Selective assay for CypA and CypB in human blood using highly specific anti-peptide antibodies. J. Immunol. Methods 178: 113-120.
14. Kim, S.-H., S. M. Lessner, Y. Sakurai, and Z. S. Galis. 2004. Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am. J. Pathol. 164: 1567-1574.
15. Xu, Q., M. C. Leiva, S. A. Fischkoff, R. E. Handschumacher, and C. R. Lyttle. 1992. Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267: 11968-11971.
16. Allain, F., C. Vanpouille, M. Carpentier, M. C. Slomianny, S. Durieux, and G. Spik. 2002. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. USA 99: 2714-2719.
17. Yurchenko, V., M. O'Connor, W. W. Dai, H. Guo, B. Toole, and M. Bukrinsky. 2001. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun. 288: 786-788.
18. Kasinrerk, W., N. Tokrasinwit, and P. Phunpae. 1999. CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-a/ICAM-1 pathway. Immunology 96: 184-192.
19. Kasinrerk, W., E. Fiebiger, I. Stefanova, T. Baumruker, W. Knapp, and H. Stockinger. 1992. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J. Immunol. 149: 847-854.
20. Yurchenko, V., G. Zybarth, M. O'Connor, W. W. Dai, G. Franchin, T. Hao, H. Guo, H. C. Hung, B. Toole, P. Gallay, et al. 2002. Active-site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277: 22959-22965.
21. Yurchenko, V., S. Constant, and M. Bukrinsky. 2005. Dealing with the family: CD147 interactions with cyclophilins. Immunology 117: 301-309.
22. Billich, A., G. Winkler, H. Aschauer, A. Rot, and P. Peichl. 1997. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J. Exp. Med. 185: 975-980.
23. Tegeder, I., A. Schumacher, S. John, H. Geiger, G. Geisslinger, H. Bankg, and K. Brune. 1997. Elevated serum cyclophilin levels in patients with severe sepsis. J. Clin. Immunol. 17: 380-386.
24. Konttinen, Y. T., T. F. Li, J. Mandelin, M. Liljestrom, T. Sorsa, S. Santavirta, and I. Virtanen. 2000. Increased expression of exracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum. 43: 275-280.
25. Tomita, T., T. Nakase, M. Kaneko, K. Shi, K. Takahi, T. Ochi, and H. Yoshikawa. 2002. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 46: 373-378.
26. Zhu, P., J. Ding, J. Zhou, W.-J. Dong, C.-M. Fan, and Z.-N. Chen. 2005. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res. Ther. 7: R1023-R1033.
27. Arora, K., W. Gwinn, M. Bower, A. Watson, I. Okwumabua, H. MacDonald, M. Bukrinsky, and S. Constant. 2005. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 175: 517-522.
28. Dent, L. A. 2002. For better or worse: common determinants influencing health and disease in parasitic infections, asthma and reproductive biology. J. Reprod. Immunol. 57: 255-272.
29. Lee, N., M. McGarry, K. Larson, M. Horton, A. B. Kristensen, and J. J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158: 1332-1344.
30. Renno, T., A. Wilson, C. Dunkel, I. Coste, K. Maisnier-Patin, A. Benoit de Coignac, J. P. Aubry, R. K. Lees, J. Y. Bonnefoy, H. R. MacDonald, and J. F. Gauchat. 2002. A role for CD147 in thymic development. J. Immunol. 168: 4946-4950.
31. Walter, D. M., J. J. McIntire, G. Berry, A. N. J. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167: 4668-4675.
32. Borchers, M., T. Ansay, R. DeSalle, B. Daugherty, H. Shen, M. Metzger, N. Lee, and J. Lee. 2002. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J. Leukocyte Biol. 71: 1033-1041.
33. Grimaldi, J., N. Yu, G. Grunig, B. Seymour, F. Cottrez, D. Robinson, N. Hosken, W. Ferlin, X. Wu, H. Soto, et al. 1999. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J. Leukocyte Biol. 65: 846-853.
34. Adler, A., G. Cieslewicz, and C. Irvin. 2004. Unrestrained plethymosgraphy is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J. Appl. Physiol. 97: 286-292.
35. Koch, C., G. Staffler, R. Huttinger, I. Hilgert, E. Prager, J. Cerny, P. Steinlein, O. Majdic, V. Horejsi, and H. Sockinger. 1999. T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int. Immunol. 11: 777-786.
36. Fujitani, Y., Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade. 2002. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J. Immunol. 168: 443-449.
37. Itami, D. M., T. M. Oshiro, C. A. Araujo, A. Perini, M. A. Martins, M. S. Macedo, and M. F. Macedo-Soares. 2005. Modulation of experimental asthma by Ascaris suum components. Clin. Exp. Allergy 35: 873-879.
38. Nagase, H., K. Kudo, S. Izumi, K. Ohta, N. Kobayashi, M. Yamaguchi, K. Matsushima, Y. Morita, K. Yamamoto, and K. Hirai. 2001. Chemokine receptor expression profile of eosinophils at inflamed tissue sites: decreased CCR3 and increased CXCR4 expression by lung eosinophils. J. Allergy Clin. Immunol. 108: 563-569.
39. Justice, J., M. Borchers, J. Crosby, E. Hines, H. Shen, S. Ochkur, M. McGarry, N. Lee, and J. Lee. 2003. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am. J. Physiol. 284: L169-L178.
40. Cormier, S., A. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. Ochkur, K. O'Neill, D. Colbert, et al. 2006. Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J. Leukocyte Biol. 79: 1131-1139.
41. Denys, A., F. Allain, M. Carpentier, and G. Spik. 1998. Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes. Biochem. J. 336: 689-697.
42. Foster, P. S., A. W. Mould, M. Yang, J. Mackenzie, J. Mattes, S. P. Hogan, S. Mahalingam, A. N. J. McKenzie, M. E. Rothenberg, I. G. Young, et al. 2001. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179: 173-181.
43. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162: 2477-2487.
44. Wardlaw, A. J. 1999. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J. Allergy Clin. Immunol. 104: 917-926.
45. Horie, S., Y. Okubo, M. Hossain, E. Sato, H. Nomura, S. Koyama, J. Suzuki, M. Isobe, and M. Sekiguchi. 1997. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern. Med. 36: 179-185.
46. Boyce, J. A., and K. F. Austen. 2005. No audible wheezing: nuggets and conun-drums from mouse asthma models. J. Exp. Med. 201: 1869-1873.
47. Hamelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155: 819-825.
48. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wierner-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183: 109-117.
49. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
50. Webb, D. C., A. N. J. McKenzie, A. M. L. Koskinen, M. Yang, J. Mattes, and P. S. Foster. 2000. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 165: 108-113.
51. Grunig, G., M. Warnock, A. E. Wakil, R. Vankayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
52. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
53. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erie. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus production in asthma. Nat. Med. 8: 885-889.
54. Whittaker, L., N. Niu, U.-A. Temann, A. Stoddard, R. A. Flavell, A. Ray, R. J. Homer, and L. Cohn. 2002. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CDT cells and interleukin-9. Am. J. Respir. Cell Mol. Biol. 27: 593-602.
55. Wills-Karp, M. 2004. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202: 175-190.
56. Coste, I., J. Gauchat, A. Wilson, S. Izui, P. Jeannin, Y. Delneste, H. MacDonald, J. Bonnefoy, and T. Renno. 2001. Unavailability of CD147 leads to selective erythrocyte trapping in the spleen. Blood 15: 3984-3988.
57. Kirk, P., M. C. Wilson, C. Heddle, M. H. Brown, A. N. Barclay, and A. P. Halestrap. 2000. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 19: 3896-3904.
58. Wilson, M., D. Meredith, J. Fox, C. Manoharan, A. Davies, and A. P. Halestrap. 2005. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4. J. Biol. Chem. 280: 27213-27221.